Showing results (201-210 of 400) with videos related to
Sort By:
Pageof 40
Anesthesiology|January 1, 1991
Halothane potentiates the antitumor activity of gamma-interferon and mimics calmodulin-blocking agentsS Rudnick, G W Stevenson, S C Hall, et al.The Journal of Experimental Medicine|May 1, 1985
Absence of the Lyt-2-,L3T4+ lineage of T cells in mice treated neonatally with anti-I-A correlates with absence of intrathymic I-A-bearing antigen-presenting cell functionA M Kruisbeek, J J Mond, B J Fowlkes, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 23, 1997
Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2M C Bosco, I Espinoza-Delgado, T K Rowe, et al.Blood|March 1, 1992
Histogenetic correlations between subcategories of small noncleaved cell lymphomasT Yano, J H van Krieken, I T Magrath, et al.The Journal of Experimental Medicine|January 1, 1985
Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell functionA Muraguchi, J H Kehrl, D L Longo, et al.Journal of Molecular Neuroscience : MN|February 28, 2002
Identification of maze learning-associated genes in rat hippocampus by cDNA microarrayY Luo, J M Long, E L Spangler, et al.Cancer Research|July 1, 1989
Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude miceJ W Pearson, D J FitzGerald, M C Willingham, et al.Seminars in Oncology|December 1, 1992
Recent National Cancer Institute lymphoma trials of etoposide-containing combination chemotherapyW J Urba, W H Wilson, P L Duffey, et al.Seminars in Hematology|April 1, 1988
The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatmentR C Young, D L Longo, E Glatstein, et al.Experimental Hematology|June 1, 1993
Increased granulopoiesis after sequential administration of transforming growth factor-beta 1 and granulocyte-macrophage colony-stimulating factorK Hestdal, S E Jacobsen, F W Ruscetti, et al.Pageof 40